scispace - formally typeset
N

Nora D. Volkow

Researcher at National Institute on Drug Abuse

Publications -  1038
Citations -  121498

Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.

Papers
More filters
Posted ContentDOI

COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after Omicron emerged in the US

TL;DR: COVID infections occurring when the Omicron predominated were associated with significantly less frequent severe outcomes than in matched patients when the Delta variant predominated, and there were significant racial/ethnic and gender disparities in severe clinical outcomes.
Journal ArticleDOI

Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?

TL;DR: MBC practice principles can help promote patient‐centred care in OUD, personalized addiction therapeutics and facilitate communication of outcomes, and can be used to tailor and adapt MOUD treatment to increase engagement, retention and effectiveness.
Proceedings Article

Modeling Neuronal Interactivity using Dynamic Bayesian Networks

TL;DR: It is demonstrated that incorporation of computer science principles into functional neuroimaging clinical studies provides a novel approach for probing human brain function, using Dynamic Bayesian Networks (DBNs) as generative models for brain activation patterns.
Journal ArticleDOI

Altered Interactions Among Resting-State Networks in Individuals with Obesity.

TL;DR: The aim of this study was to investigate alterations in functional connectivity within and interactions between resting‐state networks involved in salience, executive control, and interoception in participants with obesity (OB).
Journal ArticleDOI

Binding of d-threo-[11C]methylphenidate to the dopamine transporter in vivo: insensitivity to synaptic dopamine.

TL;DR: In positron emission tomographic (PET) baboon studies [11C]d-threo-methylphenidate binding was insensitive to drugs expected to lower endogenous dopamine, and will not affect PET measures of dopamine transporter availability.